NCT02559583

Observational Study in Participants With Chronic Lymphocytic Leukemia (CLL), Multiple Myeloma (MM) and Non-Hodgkin's Lymphoma (NHL) in Latin America

Hemato-Oncology Latin America Observational Registry in CLL, Multiple Myeloma, Non-Hodgkin Lymphoma

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 5,443 (actual)
• Sponsor: Janssen-Cilag Ltd. · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The primary purpose of the study is to quantify participants' demographic parameters, country standard therapies, treatment patterns and outcomes among participants with chronic lymphocytic leukemia (CLL), multiple myeloma (MM) and non-Hodgkin's lymphoma (NHL) in oncology concentration hospitals in Latin America.

Detailed description

This is a retrospective (take a look back at events that already have taken place), non-interventional, multicenter (when more than one hospital or medical school team work on a medical research study) study to review medical records of adult participants with a diagnosis of CLL, MM or NHL anytime since 01 January 2006. Only data available from clinical practice will be collected. All eligible participants at participating centers will be included regardless of participant's demographics, prior or current treatments for disease, or clinical outcome. The period of observation will span from 01 January 2006 through present, but all eligible participants must be followed for a minimum of 1 year, unless the participant died within that first year. Participant demographic parameters, standard therapies, treatment patterns and outcomes will be primarily quantified.

Conditions

• Multiple Myeloma
• Leukemia
• Lymphoid
• Lymphoma
• Non-Hodgkin

Interventions

Type	Name	Description
OTHER	Chronic Lymphocytic Leukemia (CLL)	This is observational study. Participants with Chronic Lymphocytic Leukemia (CLL) will be observed for 1 year.
OTHER	Multiple Myeloma (MM)	This is observational study. Participants with Multiple Myeloma (MM) will be observed for 1 year.
OTHER	Non-Hodgkin's lymphoma (NHL)	This is observational study. Participants with non-Hodgkin's lymphoma (NHL) will be observed for 1 year.

Timeline

• Start date: 2014-07-01
• Primary completion: 2016-06-01
• Completion: 2016-06-01
• First posted: 2015-09-24
• Last updated: 2016-07-20

Locations

23 sites across 7 countries: Argentina, Brazil, Chile, Colombia, Guatemala, Mexico, Panama